Literature DB >> 25410032

Wait and see: a 5 year history of 'recurrent dementia'.

Roberto D'Angelo1, Rita Rinaldi1, Piero Parchi2, Fabio Cirignotta3.   

Abstract

Rapid evolving cognitive impairment can be the onset of either a progressive or a treatable dementia. We describe a case of a man in whom the clinical and laboratory presentation suggested a diagnosis of Creutzfeldt-Jakob disease, which subsequently turned into a diagnosis of voltage-gated potassium channel complex antibodies limbic encephalitis. The natural history and an increased knowledge of limbic encephalitis and the related antibodies led us to the correct diagnosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25410032      PMCID： PMC4244331          DOI： 10.1136/bcr-2014-205991

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

1.  Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease.

Authors:  Koji Fujita; Tatsuhiko Yuasa; Osamu Watanabe; Yukitoshi Takahashi; Shuji Hashiguchi; Katsuhito Adachi; Yuishin Izumi; Ryuji Kaji
Journal:  J Neurol       Date:  2012-05-26       Impact factor: 4.849

2.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

Review 3.  Autoantibodies associated with diseases of the CNS: new developments and future challenges.

Authors:  Angela Vincent; Christian G Bien; Sarosh R Irani; Patrick Waters
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

4.  Prion disease: diagnostic value of cerebrospinal fluid markers.

Authors:  Piero Parchi; Sabina Capellari
Journal:  Nat Rev Neurol       Date:  2012-12-04       Impact factor: 42.937

5.  The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.

Authors:  G Chohan; C Pennington; J M Mackenzie; M Andrews; D Everington; R G Will; R S G Knight; A J E Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-20       Impact factor: 10.154

6.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

7.  Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Authors:  Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis; Jerzy Kulczycki; Dana Slivarichova; Albert Saiz; Miguel Calero; Richard Knight; Adriano Aguzzi; Jean-Louis Laplanche; Katell Peoc'h; Gabi Schelzke; Andre Karch; Cornelia M van Duijn; Inga Zerr
Journal:  Brain       Date:  2012-09-25       Impact factor: 13.501

Review 8.  Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition.

Authors:  Luigi Zuliani; Francesc Graus; Bruno Giometto; Christian Bien; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-03-24       Impact factor: 10.154

9.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

10.  Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease.

Authors:  Lynne I McGuire; Alexander H Peden; Christina D Orrú; Jason M Wilham; Nigel E Appleford; Gary Mallinson; Mary Andrews; Mark W Head; Byron Caughey; Robert G Will; Richard S G Knight; Alison J E Green
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.